ReviewBiological psychiatry2026
Sleep and Drug Use: Neuroimaging Evidence for a Multidimensional Brain Framework.
Review in Biological psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Sleep plays a critical role in the initiation and maintenance of drug use, as well as recovery among individuals with substance use disorders. Sleep is a multidimensional construct, and a growing body of research has demonstrated the relative independence of various components. Specific sleep characteristics including insomnia (self-reported sleep disturbances), short sleep duration, late sleep timing and sleep irregularity have each been associated with increased risks of drug use. However, it remains unclear whether these sleep components contribute to substance use through shared neurobiological pathways. Conversely, drug use across different drug classes disrupts sleep. The extent to which drug-induced alterations in brain circuits account for shared and drug class-specific sleep disturbances remains poorly understood. In this review, we synthesize evidence from human neuroimaging studies to map sleep components predictive of drug use onto brain regions and large-scale brain networks. The anterior cingulate, insular and orbitofrontal cortices emerge as the brain regions most consistently implicated across sleep dimensions, and these regions play a key role in drug use initiation. We further discuss how chronic use of different drug classes also disrupts these brain regions and broader neural circuits involved in sleep regulation, thereby exacerbating initial sleep disturbances and potentially extending their effects to other sleep dimensions. This review underscores the importance of integrating multimodal sleep and neuroimaging assessments to advance the neurobiological understanding of the bidirectional relationship between sleep, drug use and addiction and highlights directions for future research.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.